PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcbioiBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Bioinformatics
 
BMC Bioinformatics. 2007; 8: 128.
Published online Apr 18, 2007. doi:  10.1186/1471-2105-8-128
PMCID: PMC1868768
TagSmart: analysis and visualization for yeast mutant fitness data measured by tag microarrays
Reviewed by Chulyun Kim,1,6 Sangkyum Kim,1 Russell Dorer,3 Dan Xie,2 Jiawei Han,1 and Sheng Zhongcorresponding author1,2,4,5
1Department Computer Science, University of Illinois at Urbana Champaign, Urbana, IL, USA
2Department of Bioengineering, University of Illinois at Urbana Champaign, Urbana, IL, USA
3Department of Pathology, Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA, USA
4Department of Statistics, University of Illinois at Urbana Champaign, Champaign, IL, USA
5Institute for Genomic Biology, University of Illinois at Urbana Champaign, Urbana, IL, USA
6School of Electrical Engineering and Computer Science, Seoul National University, South Korea
corresponding authorCorresponding author.
Chulyun Kim: ckim5/at/uiuc.edu; Sangkyum Kim: kim71/at/uiuc.edu; Russell Dorer: russell.dorer/at/vmmc.org; Dan Xie: danxie2/at/uiuc.edu; Jiawei Han: hanj/at/cs.uiuc.edu; Sheng Zhong: szhong/at/uiuc.edu
Received June 12, 2006; Accepted April 18, 2007.
Background
A nearly complete collection of gene-deletion mutants (96% of annotated open reading frames) of the yeast Saccharomyces cerevisiae has been systematically constructed. Tag microarrays are widely used to measure the fitness of each mutant in a mutant mixture. The tag array experiments can have a complex experimental design, such as time course measurements and drug treatment with multiple dosages.
Results
TagSmart is a web application for analysis and visualization of Saccharomyces cerevisiae mutant fitness data measured by tag microarrays. It implements a robust statistical approach to assess the concentration differences among S. cerevisiae mutant strains. It also provides an interactive environment for data analysis and visualization. TagSmart has the following advantages over previously described analysis procedures: 1) it is user-friendly software rather than merely a description of analytical procedure; 2) It can handle complicated experimental designs, such as multiple time points and treatment with multiple dosages; 3) it has higher sensitivity and specificity; 4) It allows users to mask out "bad" tags in the analysis.
Two biological tests were performed to illustrate the performance of TagSmart. First, we generated titration mixtures of mutant strains, in which the relative concentration of each strain was controlled. We used tag microarrays to measure the numbers of tag copies in each titration mixture. The data was analyzed with TagSmart and the result showed high precision and recall. Second, TagSmart was applied to a dataset in which heterozygous deletion strain mixture pools were treated with a new drug, Cincreasin. TagSmart identified 53 mutant strains as sensitive to Cincreasin treatment. We individually tested each identified mutant, and found 52 out of the 53 predicted mutants were indeed sensitive to Cincreasin.
Conclusion
TagSmart is provided "as is" to analyze tag array data produced by Affymetrix and Agilent arrays. TagSmart web application is assessable by Windows, Mac, and Linux users. It also has a downloadable version for execution on PCs running Windows. TagSmart is available for academic use at: http://biocomp.bioen.uiuc.edu/tagsmart
A nearly complete collection of gene-deletion mutants (96% of annotated open reading frames) of the yeast Saccharromyces cerevisiae has been systematically constructed [1,2]. Each deletion is marked with two unique oligonucleotide tags, making it possible to use microarrays and the tag arrays [3] to measure the relative abundance of each mutant strain in a mixture. The relative fitness of every individual gene deletion mutant can be compared across multiple intercellular environments. A general question of interest is which gene-deletion and environment interaction is most lethal or most viable.
Every mutant is barcoded with two tags, namely the uptag and the downtag. The two tags are deletion-specific. They are synthesized into the genome of the deletion strain at the location of the deleted gene. For Affymetrix tag arrays, four probes on the microarray are designed to hybridize to the sense and antisense strands of each tag. These probe sets are indicated by Perfect Match (PM), Mis-Match (MM), complementary Perfect Match (cPM), and complementary Mis-Match (cMM). In summary, every mutant strain is represented by eight probe readouts: uptag-PM, uptag-cPM, uptag-MM, uptag-cMM, downtag-PM, downtag-cPM, downtag-MM, downtag-cMM [Additional file 1]. Please refer to [4] for details of Agilent tag arrays.
A general experiment design is a two-environment, multiple-time-point design [1,2,5]. Two mixtures of gene-deletion mutants are grown under two different environmental conditions: a drug-treated condition and a control condition. Mutant samples are collected from both collections at a series of time points, e.g., 4, 8, and 16 cell generations. DNA of these samples are retrieved, amplified, and hybridized to tag arrays. We summarize the experimental designs and analytical procedures in published literature at below and in Table Table11.
Table 1
Table 1
Summary of experimental design and data structure in previous studies.
A few analytical procedures have been proposed to analyze tag microarray data. (see Additional file 2 for a detailed review of these procedures.) Most of these procedures were designed to handle a specific dataset generated by a specific experiment, and therefore are not applicable to analyzing other data generated from a different experimental design, with exceptions to the procedure described by Giaever et al. [2] and the procedure we recently proposed [5]. The latter procedure is more general than the Giaever procedure because it can handle treatment with multiple dosages. The TagSmart software implements the latter procedure (hereafter referred to as the TagSmart procedure). When there is a complex experimental design (e.g., multiple time points, or multiple dosages), TagSmart will take the most advantage of the comprehensive data available. When data is generated from a simple experimental design, the TagSmart procedure will automatically degenerate into a simpler procedure.
2.1 TagSmart software
TagSmart [3] is a web application that can be operated by web browsers, such as Mozilla Firefox, Safari, and Internet Explorer. TagSmart also has a downloadable version for execution on PCs running on Windows. TagSmart has three modules: data preprocessing, computation, and visualization.
Data preprocessing module
The data preprocessing module integrates data files and annotation files into one easily interpretable data file. The following files are required as input files to the preprocessing module: 1) a series of tag array data files, in either CEL or TXT format; 2) a chip description file (CDF file); 3) an array description file; 4) a tag mask file; and 5) a user-supplied experiment description file. Except that the tag array data files and experiment description file should be provided by the user, all the other files can be downloaded from the TagSmart website. The CEL format data files are direct outputs of an Affymetrix scanner. If users have applied Affymetrix software such as GCOS [3] to process the data, they may have data files in TXT format. TagSmart allows users to supply data files in either CEL or TXT format. The CDF file records the coordinates of each tag on the tag microarray. The array description file links each tag to its corresponding open reading frame and gene name. Because the same tag was used to make both the homozygous deletion mutant [1] and the heterozygous deletion mutant [6], the analysis of heterozygous and homozygous mutants share the same array description file (the analysis of homozygous mutants only uses a subset of this file). The tag mask file records a list of tags that do not show "responsiveness" to the concentration change of their corresponding mutants. These tags are considered to be bad (the procedure of detecting bad tags will be described later). The user can choose to mask out the "bad" tags in the subsequent analysis by clicking on the "Bad tag filtering" checkbox (Additional file 3). Finally, the experiment description file is a user-supplied file, recording the experimental condition (e.g., treated/control, dosage, time, etc.) for each array data file. Users should follow the instruction on the TagSmart help-page to construct this file. The output of the preprocessing module is an easily interpretable data file in tabular format. Instead of averaging the multiple signals of a mutant (e.g., four PM signals in the Affymetrix platform), the preprocessing module retains them individually in the output.
Computation module
By choosing the radio button of "Analyze a preprocessed data file" in the main page, users activate the computation module. Users should specify desired criteria for selecting mutants in the subsequent webpage (Additional file 4). Fold Change (FC) and Q-value (equivalent to false discovery rate) are allowed. If the user has array data for a common pool of mutant mixture, such as a time 0 sample before the separation of mutant growth in treatment and control, she/he can choose to use such data to get more precise estimate of mutant growth rates. This is achieved by checking the "Generation-0 correction" check box (The procedure to handle a common mixture pool will be described later). Advanced users are also allowed to tune a parameter called the number of permutations. As in the Statistical Procedure section described below, TagSmart employs a matched permutation method to obtain background distribution. The number of permutation is positively correlated with the accuracy of computation but also computation time. We suggest a default number of 500 permutations, which is a balance between accuracy and time. Additional file 5 gives an example text output of a computation. Mutants that satisfied the user-defined thresholds are listed. Their related information, including open reading frame's name (ORF), gene name, the two associated tags, p-value, q-value, and fold change are provided. Users can sort the output by any information with a click on the corresponding column name. A more comprehensive report, including the actual data and experimental conditions, can be saved as a text file by clicking the disk icon on the output webpage.
Visualization module
An interactive graphical display of the computation result is accessible by clicking the "heatmap" icon after the computation (Figure (Figure1A).1A). Alternatively, the saved report file on a user's local computer can be uploaded onto the server and visualized using the visualization module. TagSmart adopts heatmap as the way to present mutant's relative concentration. The first two rows in the heatmap use a novel color scheme to represent experimental design information. The first row represents the treatment factor (treatment 0, treatment 1, etc.). The second row represents the time factor (Generation 0, Generation 4, etc.). From the third row on, a traditional heatmap is applied to show the relative concentration of each mutant. Red represents higher concentration and green represents lower concentration. Detailed information on treatment, time, and array signal can be monitored by moving mouse cursor over the corresponding color-coded region (Figure (Figure1B1B and and1C1C).
Figure 1
Figure 1
(A) An example TagSmart's graphical output. Every mutant is represented in 4 rows, representing signals from four tag-probe pairs (uptag-PM, uptag-cPM, downtag-PM, and downtag-cPM). The arrays are sequentially marked on the top row. The first two colored (more ...)
We tested TagSmart with multiple web browsers under Linux, MacOS, and Windows operation systems. TagSmart is implemented with C# programming language and ASP.NET technology. TagSmart is currently hosted on a Dell rack server with dual 3 GHz Intel(R) Xeon(TM) dual-core processors and 6GB RAM. A standalone executable for Windows is also downloadable from the TagSmart website.
2.2. Statistical Procedure
We describe TagSmart's statistical procedure assuming data comes from the most complicated setting (i.e., multiple time points and treatment with multiple dosages). This procedure automatically degenerates into a simpler procedure when data comes from a simpler experimental design.
Array signals are first normalized to make 1% trimmed mean the same across all arrays [7]. Let yiαβγδτ be the normalized signal for mutant i, in environmental condition α, at time point β, measured by tag γ (uptag and downtag) and probe δ (PM and cPM), on the replicate array τ. For notational simplicity, we will suppress the mutant indicator i hereafter. When time-0 data is available, users can use the following metric to represent the growth rate measured by a probe at time β: equation M1, where equation M2 is the average across all array replicates at time-0. The growth rate measurement xαβγδτ was inspired by the Coefficient of Variation (CV) statistic. With the observation that signals with larger magnitude usually have larger variability, xαβγδτ can be regarded as a signal for concentration change, with the raw signal intensity penalized. When time-0 data is not available, the normalized signal is directly passed onto the next step: xαβγδτ = yαβγδτ.
To compare the difference of concentration changes between different experimental conditions, we first compute a modified T statistic:
equation M3
where equation M4 and equation M5 are average concentration changes under treated and untreated conditions, respectively. If the treatment was conducted with multiple dosages, equation M6 is computed with all the data from all dosages. s is the pooled standard deviation of all data. It is computed by:
equation M7
where equation M8 denotes sum over all treated signals. If there are multiple dosages, all these dosages should be summed. n1 and n2 are the numbers of x s under treated and untreated conditions, respectively. s0 is a small positive constant (0.001) that ensures T not outrageously large.
We use a matched permutation strategy to generate background distribution for the T statistic. To illustrate the matched permutation procedure, we assume that data comes from the following hypothetical experiment. Let A and B denote two mutant mixtures treated with high and low dosages of a drug, respectively. Mutant mixtures C and D are replicates grown under control condition. Mutant samples are collected at 5 and 15 cell generations. In this hypothetical experiment, 8 tag arrays are used to gather data. We permute xαβγδτ with the same time (β), tag (γ), and probe (δ). To see this permutation procedure graphically, signals are arranged in Figure Figure22 and color coded. The signals are permutated under the constraint that a signal can only be switched to a box with the same color as its original one.
Figure 2
Figure 2
Data table for a mutant in a hypothetical experiment. This hypothetical experiment has two replicate mutant mixtures in control condition, and two treated mixtures under different treatment dosage. Mutant samples were harvested at both cell generations (more ...)
With K permutations, we obtain K new statistics Tk, k = 1, 2, ..., K. We compute a q-value (roughly equivalent to false discovery rate [8]) for every mutant. The statistical interpretation for a mutant's q-value is: if the threshold is set so that this mutant is the last mutant to be called significant, the q-value is the estimated percentage of false positives among all the mutants being called significant. We compute the q-value for a mutant by [9,10]:
equation M9, where j = 1, 2, ..., N is the index for mutants. T is the T-statistic computed from un-permuted data. equation M10 is the estimated proportion of mutants with no fitness difference between experimental conditions. equation M11 is estimated by [9,10]:
equation M12, and C0 is a pre-defined constant (0.5). The choice of C0 does not affect the estimate of equation M13 as long as C0 is reasonably small [8,9].
Finally, the fold change (FC) between treatment and control is computed by:
equation M14. It is a weighted sum of each time point fold change. We require equation M15. Larger aβ will stress the importance of that β time point. FCβ is the fold change at time β. It is defined as:
equation M16
where α, β, γ, δ, and τ are defined the same as above. It is worth noticing that TagSmart does not first average all probe signals and then take the ratio, but rather it first takes ratio on the same probe and then averages over all tags and probes. TagSmart jointly uses q-value and FC to call significant mutants.
Titration Experiment
To illustrate TagSmart's performance, we did a titration experiment using homozygous deletion mutants. Eight mutant mixture pools were made, which were denoted as pools A, B, C, D, E, F and G, respectively. The mutants had roughly equal concentrations in mixture pools A and G. One sixth of the mutants were diluted into 1/25 concentration whereas the concentration of the rest mutants were untouched in pool B. Another one sixth, not overlapping with the first one sixth, were diluted to 1/25 concentration in pool C, so did pools D, E, and F. In the end pools B to F each had one sixth of the mutants diluted. DNA from each mutant pool was hybridized to a tag microarray. TagSmart procedure was applied to identify the mutants with lower concentration in pools C to G. A wide range of thresholds for determining the mutants with lower concentration were applied, and for each threshold the computationally identified mutants were compared to the real diluted mutants. We computed the precision and the recall of TagSmart procedure (Figure (Figure3).3). Precision and recall are defined as follows.
Figure 3
Figure 3
Precision vs. Recall for TagSmart. The six panels represent the mutant mixture pools B-F, respectively. For a wide range of thresholds, the precision and the recall from TagSmart are plotted, and a linear regression line is fitted.
equation M17
equation M18
Figure Figure33 shows that at the precision of 0.4, TagSmart achieves recalls of 0.7 to 0.9 in the titration data.
The titration experiment allows us to detect the "bad" tags that do not show consistent signal change for the diluted mutants. Each mutant is diluted in one of the eight mixture pools. The diluted concentration is 1/25 of the concentration of the undiluted concentration. We employed the following procedure to detect "bad" tags. For each tag, its signal from the diluted pool is compared to the average signal of this tag from the other seven undiluted pool (each mutant is only diluted in one of the eight pools). A tag is regarded as "bad" if its signal from the diluted pool is not smaller than its average signal from the undiluted pools. The "bad" tags are recorded into the tag mask file, which, by user's discretion, can be used to eliminate the bad tags from the subsequent analysis (see the preprocessing module). One reason for a tag being "bad" can attribute to the mutations of the synthetic DNA tags introduced during the construction of the deletion strains [11]. We note that a "bad" tag should not be taken literally, because there are many reasons that can contribute to inconsistency between the signal of a tag and the concentration change. For example, cross-hybridization to the probe on the array may contribute to the inconsistency.
Cincreasin experiment
To illustrate the power of TagSmart in a real biological investigation, we applied TagSmart on a tag array dataset [5]. This dataset records the tag array measurements of heterozygous deletion mutants under four experimental conditions, including rich medium (control), 100, 200, and 400 uM treatment of a chemical called Cincreasin. Cincreasin is a newly synthesized molecule that inhibits the spindle checkpoint process by targeting Mps1 protein [5]. Additional file 6 summarizes this dataset. We restricted our analysis on 200 uM treatment data only.
TagSmart identified 53 mutants as sensitive to Cincreasin treatment (q-value = 1%, FC = 0.5, Additional file 7). Additional file 8 shows the fold changes of top 10 most sensitive mutants. Among theses mutants, Mps1 was shown to be the direct target of Cincreasin [5]. Mps1 is a dual-specificity kinase required for spindle pole body duplication and spindle checkpoint function [12]. Cincreasin blocks the spindle checkpoint response to a lack of tension on mitotic chromosome by inhibiting Mps1. However, the other mutants besides Mps1 being sensitive to Cincreasin might indicate that there is an aftermath of chained molecular responses to the inhibition of Mps1.
To validate these findings, we re-tested all the 53 heterozygous mutants individually with Cincreasin treatment in colonial growth assay (patch test). Mutant strains were grown in colonies in the same control environment as described in [5] and in 200 uM and 400 uM Cincreasin treated environments. Three wild type colonies were grown under each environment as negative controls. Cin8 homozygous deletion strain was used as positive control (sensitive to Cincreasin treatment), because Cincreasin has been previously shown to cause mis-segregation of chromosomes in cin8 null cells (Figure (Figure33 in reference [5]). In this test, 52 out of the 53 predicted mutants showed significant sensitivity to Cincreasin in this test, comparing to three wild type colonies (Additional file 7 and Additional file 9). This high validation rate demonstrates TagSmart is very resistant to false positive reports. We recognize that due to the limited amount of mutant colonies we could test, it is infeasible for this test to address the amount of false negative reports. The titration experiment described previously in this paper did address both false positive and false negative reports.
The validated mutants fell into three classes: i) mutants with lesions in known components of the spindle, ii) mutants in genes of known function which lack any described role in chromosome segregation, and iii) mutants in genes of unknown function. The first functional category is highly relevant to the function of Cincreasin, an inhibitor of buddy yeast spindle checkout. It is worth further investigation whether the second class reflects additional molecular targets of Cincreasin that lie outside the spindle checkpoint, or previously undiscovered roles in spindle function for this class of genes.
4. Conclusion
Tag microarray data has inspired various research, including identification of gene function [1,13], identification of drug targets [5,6], and evolution and genetic robustness [14]. TagSmart is an interactive online software tool for the analysis of tag microarray data. It is freely available for non-commercial use at [3]. Our future work is to expand TagSmart for integrated analysis with other genomics data, such as expression data and double deletion mutant data.
Availability and requirements
Project name: TagSmart
Operating systems: Platform independent
Programming language: C#, ASP.NET
Other requirements: None
License: None
Restrictions to use by non-academics: licence needed
Authors' contributions
SZ conceived the study, designed the analytical procedure, the software and the biological experiments. CK, SK and JH implemented the software. SZ, CK, SK and DX analyzed the data. RD performed the biological experiments. SZ coordinated the study and wrote the paper. All authors read and approved the final manuscript.
Additional file 1
A generic gene-deletion cassette module. Supplementary figure 1
Additional file 2
Summary of previous methods. Supplementary document
Additional file 3
Screenshot of the preprocessor module. Supplementary figure 2
Additional file 4
Screenshot of the computation module. Supplementary figure 3
Additional file 5
An example text output from TagSmart server. Supplementary figure 4
Additional file 6
Summary of the Cincreasin dataset. Supplementary table 1
Additional file 7
Summary of test results by colonial assays. Supplementary table 2
Additional file 8
Fold changes of the top 10 mutants sensitive to Cincreasin treatment. Supplementary figure 5
Additional file 9
Colonial assays for testing S.cerevisiae mutants in the presence of DMSO (control) and Cincreasin (treatment). Supplementary figure 6
Acknowledgements
CK is supported by the Brain Korea 21 Project. SZ is supported by Stowers Institute for Medical Research (SIMR) and Illinois Regenerative Medicine Institute (IRMI).
  • Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, Chu AM, Connelly C, Davis K, Dietrich F, Dow SW, El Bakkoury M, Foury F, Friend SH, Gentalen E, Giaever G, Hegemann JH, Jones T, Laub M, Liao H, Davis RW, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901–906. doi: 10.1126/science.285.5429.901. [PubMed] [Cross Ref]
  • Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, Anderson K, Andre B, Arkin AP, Astromoff A, El-Bakkoury M, Bangham R, Benito R, Brachat S, Campanaro S, Curtiss M, Davis K, Deutschbauer A, Entian KD, Flaherty P, Foury F, Garfinkel DJ, Gerstein M, Gotte D, Guldener U, Hegemann JH, Hempel S, Herman Z, Jaramillo DF, Kelly DE, Kelly SL, Kotter P, LaBonte D, Lamb DC, Lan N, Liang H, Liao H, Liu L, Luo C, Lussier M, Mao R, Menard P, Ooi SL, Revuelta JL, Roberts CJ, Rose M, Ross-Macdonald P, Scherens B, Schimmack G, Shafer B, Shoemaker DD, Sookhai-Mahadeo S, Storms RK, Strathern JN, Valle G, Voet M, Volckaert G, Wang CY, Ward TR, Wilhelmy J, Winzeler EA, Yang Y, Yen G, Youngman E, Yu K, Bussey H, Boeke JD, Snyder M, Philippsen P, Davis RW, Johnston M. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 2002;418:387–391. doi: 10.1038/nature00935. [PubMed] [Cross Ref]
  • DNA TAG3, Affymetrix, Santa Clara, CA
  • Yuan DS, Pan X, Ooi SL, Peyser BD, Spencer FA, Irizarry RA, Boeke JD. Improved microarray methods for profiling the Yeast Knockout strain collection. Nucleic Acids Res. 2005;33:e103. doi: 10.1093/nar/gni105. [PMC free article] [PubMed] [Cross Ref]
  • Dorer RK, Zhong S, Tallarico JA, Wong WH, Mitchison TJ, Murray AW. A small-molecule inhibitor of Mps1 blocks the spindle-checkpoint response to a lack of tension on mitotic chromosomes. Curr Biol. 2005;15:1070–1076. doi: 10.1016/j.cub.2005.05.020. [PubMed] [Cross Ref]
  • Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, Hinshaw JC, Garnier P, Prestwich GD, Leonardson A, Garrett-Engele P, Rush CM, Bard M, Schimmack G, Phillips JW, Roberts CJ, Shoemaker DD. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell. 2004;116:121–137. doi: 10.1016/S0092-8674(03)01035-3. [PubMed] [Cross Ref]
  • Miller RGJ. Beyond ANOVA: Basics of Applied Statistics. Chapman & Hall; 1997.
  • Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440–9445. doi: 10.1073/pnas.1530509100. [PubMed] [Cross Ref]
  • Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: A unified approach. Journal of the Royal Statistical Society, Series B. 2004;66:187–205. doi: 10.1111/j.1467-9868.2004.00439.x. [Cross Ref]
  • Zhong S, Tian L, Li C, Storch KF, Wong WH. Comparative analysis of gene sets in the Gene Ontology space under the multiple hypothesis testing framework. Proc IEEE Comput Syst Bioinform Conf. 2004:425–435. [PubMed]
  • Eason RG, Pourmand N, Tongprasit W, Herman ZS, Anthony K, Jejelowo O, Davis RW, Stolc V. Characterization of synthetic DNA bar codes in Saccharomyces cerevisiae gene-deletion strains. Proc Natl Acad Sci U S A. 2004;101:11046–11051. doi: 10.1073/pnas.0403672101. [PubMed] [Cross Ref]
  • Lauze E, Stoelcker B, Luca FC, Weiss E, Schutz AR, Winey M. Yeast spindle pole body duplication gene MPS1 encodes an essential dual specificity protein kinase. Embo J. 1995;14:1655–1663. [PubMed]
  • Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, Chu AM, Jordan MI, Arkin AP, Davis RW. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A. 2004;101:793–798. doi: 10.1073/pnas.0307490100. [PubMed] [Cross Ref]
  • Gu Z, Steinmetz LM, Gu X, Scharfe C, Davis RW, Li WH. Role of duplicate genes in genetic robustness against null mutations. Nature. 2003;421:63–66. doi: 10.1038/nature01198. [PubMed] [Cross Ref]
  • Ooi SL, Shoemaker DD, Boeke JD. DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat Genet. 2003;35:277–286. doi: 10.1038/ng1258. [PubMed] [Cross Ref]
  • Ooi SL, Shoemaker DD, Boeke JD. A DNA microarray-based genetic screen for nonhomologous end-joining mutants in Saccharomyces cerevisiae. Science. 2001;294:2552–2556. doi: 10.1126/science.1065672. [PubMed] [Cross Ref]
  • Warren CD, Eckley DM, Lee MS, Hanna JS, Hughes A, Peyser B, Jie C, Irizarry R, Spencer FA. S-phase checkpoint genes safeguard high-fidelity sister chromatid cohesion. Mol Biol Cell. 2004;15:1724–1735. doi: 10.1091/mbc.E03-09-0637. [PMC free article] [PubMed] [Cross Ref]
  • Lee MS, Spencer FA. Bipolar orientation of chromosomes in Saccharomyces cerevisiae is monitored by Mad1 and Mad2, but not by Mad3. Proc Natl Acad Sci U S A. 2004;101:10655–10660. doi: 10.1073/pnas.0404102101. [PubMed] [Cross Ref]
  • Pan X, Yuan DS, Xiang D, Wang X, Sookhai-Mahadeo S, Bader JS, Hieter P, Spencer F, Boeke JD. A robust toolkit for functional profiling of the yeast genome. Mol Cell. 2004;16:487–496. doi: 10.1016/j.molcel.2004.09.035. [PubMed] [Cross Ref]
  • Birrell GW, Giaever G, Chu AM, Davis RW, Brown JM. A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity. Proc Natl Acad Sci U S A. 2001;98:12608–12613. doi: 10.1073/pnas.231366398. [PubMed] [Cross Ref]
  • Peyser BD, Irizarry RA, Tiffany CW, Chen O, Yuan DS, Boeke JD, Spencer FA. Improved statistical analysis of budding yeast TAG microarrays revealed by defined spike-in pools. Nucleic Acids Res. 2005;33:e140. doi: 10.1093/nar/gni138. [PMC free article] [PubMed] [Cross Ref]
Articles from BMC Bioinformatics are provided here courtesy of
BioMed Central